CD14 and metabolic dysfunction-associated steatohepatitis: Interestingly, the numbers of CD14 + + CD16+ intermediate and CD14 + CD16 + + nonclassical monocytes were greater in the livers of participants with T2D and NASH or liver cirrhosis than in those of participants with T2D but no NASH or cirrhosis (Fig. 3c).